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Drug related problems are an essential term in the world of
pharmaceutical care. Other terms can be used for the same concept,
such as medication errors, but this term is different from drug
related problems. The errors refer to the mistakes in the process
that could lead to problems. Drug related problems can originate
when prescribing, dispensing or taking/administering medicines.
Drug use problems by the patient are probably the most frequent,
but are not always noticed. There are several classifications for drug
related problem, but in this article the classification of the
Pharmaceutical Care Network Europe (PCNE) is used to clarify the
concepts. Some of the known classifications seem difficult to be
used in practice, and especially the reproducibility of the existing
classifications should be researched further.
The concept of pharmaceutical care
started developing in the early 1990s after
the milestone publication of Hepler and
Strand on this subject1 and some years later
Hepler depicted pharmaceutical care as a
quality improvement process (a circle of
Denning) in which the professional
improves the outcomes of pharmacotherapy.
During the quality improvement process, the
causes that potentially lead to problems
resulting from pharmacotherapy should be
identified and corrected.2 This philosophy
around optimizing the outcomes of
pharmacotherapy and pharmaceutical care
lead to the concept of Drug Related
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Problems or DRPs, indicating some problem
in the pharmacotherapy of the patients.
DRPs therefore are defined as problems in
the pharmacotherapy of the individual
patient that actually or potentially interfere
with desired health outcomes (definition
PCNE 1999). The essential element of this
definition is the impact of the problem on
the health-outcome of the
pharmacotherapy. If there is no potential
impact, then there is no drug-related
problem.
It would be much better to prevent drug
related problems than to correct them, but
this is not always possible because of the
complexity of pharmacotherapy, lack of
training and knowledge of health care
providers and the behaviour of the medicine
users. Also, some pharmacotherapy
problems are the result of an unexpected
reaction of the individual, like allergies, and
cannot always be predicted. Therefore, even
if one could analyse the medication and
patient related factors during a medication
review before a medicine is handed over to
the patient, the evaluation of the
pharmacotherapy after it has been initiated
still remains necessary to detect DRPs and
optimise outcomes.
A drug related problem is essentially
different from a medication error. According
to the NCC MERP a medication error is ‘any
preventable event that may cause or lead to
inappropriate medication use or patient
harm while medication is in the control of a
health care professional, patient, or
consumer’.3 A medication error is much more
process orientated than outcome orientated.
If something goes wrong in the prescribing
or dispensing process, then it is
automatically regarded as a medication error
whether or not there is an impact on
patient outcome. Additionally, errors in
medication use by patients seem not to be
included but such errors can be causes for
drug related problems.
Terminology
The term ‘Drug Related Problem’ is not
unique for a problem with pharmacotherapy.
Other terms have been proposed. For
instance ‘drug-therapy problem’ is often
used too, and was introduced by the group
of Cipolle, Morley and Strand.4 Krska
introduced the term ‘Pharmaceutical Care
Issue’ in 2002. That term is sometimes used
in the UK.5
Fernandez-Llimos et al. recently
proposed ‘pharmacotherapy failure’,
corresponding to negative clinical outcomes
resulting from the use or the lack of use of
medicines. Those pharmacotherapy failures
then include necessity, effectiveness and
safety problems.6
All these terms may stand for similar
concepts as drug-related problems and
therefore it remains important to define the
concept properly before using it in research
or publications.
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How and where
do DRPs originate
In the entire course of installing
pharmacotherapy there are three main
processes where a drug-related problem can
be generated: the prescribing, dispensing
and drug use process as illustrated in Fig.1
DRPs can also be split into real and
potential DRPs. Additionally some of those
problems cannot be avoided without
reducing the effect of the
pharmacotherapy, e.g. nausea as a side
effect of oncolytic medicines, or
interactions between different medications
for AIDS.
Prescribing problems originate usually
behind the physicians’ desk, or sometimes
at the bedside. Usually negligence or lack
of knowledge may cause such problems,
sometimes lack of information regarding
the full therapeutic profile of the patient,
and at times possibly also missing
laboratory data. The physician can also be
influenced by external entities, such as the
pharmaceutical industry, and may not
prescribe the most appropriate medicine.
Nurses may also cause DRPs by wrongly
copying the physicians’ instructions on a
chart or order form, or by not providing
medication as intended.
Dispensing problems also are often a
result of negligence. Misinterpreting the
physicians’ handwriting, not performing a
drug use review, taking the wrong box or
bottle may all cause DRPs.
Drug use problems by the patient
probably occur very frequently, but are not
always noticed. In general, half of the
patients do not adhere to the
pharmacotherapy. This leads to a significant
Figure 1: The scenery of drug-related problems
amount of drug related problems, but only
part of those problems are detected e.g.
when the patient is taken to the emergency
department of a hospital for not taking
insulin.
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Mrs A, an 87 year old lady, has been taking digoxin 0.25 mg daily for her atrial
fibrillation for 3 years. Recently you have noticed that she is getting increasingly
frail and may have lost weight. On a Saturday morning  she presents a new
prescription for digoxin. While you prepare the prescription, she tells you that she
has been having visual disturbance and wonders if she needs her glasses replaced.
You recognise the possible side effect of the digoxin and tell her not to take the
digoxin for one day and to go to her GP on Monday to explain her symptoms.
There clearly is a DRP, a problem with the pharmacotherapy, because the visual
disturbance is most probably due to high plasma levels of the digoxin. The probable
cause of the problem is  too high a dose as a result of a lack of therapeutic drug
monitoring.
If this problem must be documented or registered, a classification that is
especially designed for DRPs can be used. The PCNE-DRP classification is an example
of such a documentation tool. The global outline of this classification is illustrated
in Table 1
In the case of the woman with the digoxin, P1 and C1 plus C2 would be the
appropriate coding choices because the patient suffers from an adverse drug event,
caused by an issue in the drug use process. However, this description does not
provide much information. Therefore, in the PCNE classification, a second more
detailed information level is available. Then the coding would read as P1.3, C2.4,
I2.3 and I3.5 (see also Table 2).
One will also need some extra patient and drug data in order to document a
drug related problem like gender and age and ATC-code.* A form to document drug
related problems is illustrated in Figure 2.
Example of a Drug Related Problem - Case study
* A coding system for medicines compiled by the WHO: the Anatomic Therapeutic Classification.
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Code Domains
Problems P1 Adverse reaction(s)
Patient suffers from an adverse drug event
P2 Drug Choice Problem
Patient gets or is going to get a wrong (or no drug)
drug for his/her disease and/or condition
P3 Dosing problem
Patient gets more or less than the amount of drug
he/she requires
P4 Drug Use/Administration Problem
Wrong or no drug taken/administered
P5 Interactions
There is a manifest or potential drug-drug
or drug-food interaction
P6 Other
Causes C1 Drug/Dose Selection
The cause of the DRP can be related to the selection
of the drug and/or dosage schedule
C2 Drug Use Process
The cause of the DRP can be related to the way
the patient uses the drug, in spite of proper dosage
instructions (on the label)
C3 Information
The cause of the DRP can be related to a lack or
misinterpretation of information
C4 Patient/Psychological
The cause of the DRP can be related to
the personality or behaviour of the patient.
C5 (Pharmacy) Logistics
The cause of the DRP can be related to the logistics
of the prescribing or dispensing mechanism
C6 Other
Interventions I0 No intervention
I1 At prescriber level
I2 At patient (or carer) level
I3 At drug level
I4 Other
Outcome S1 Problem totally solved
of intervention S2 Problem partially solved
S3 Problem not solved
Table 1: The first level domains of the PCNE-classification V. 5
Code Description Subdomain
Problems P1.3 Toxic effects suffered
Causes C1.2 Inappropriate dosage selection
C2.4 Therapeutic drug level not monitored
Intervention I2.3 Patient referred to prescriber
I3.5 Drug stopped
† This section is partially based upon a document of
the National Centre for Health Outcomes
Development at the University of Oxford. Source
original document: http://phi.uhce.ox.ac.uk/, last
accessed 12-07-2004.
Table 2: PCNE V 5.01 codes for the example case
Classifications
There are many classifications available
to code drug related problems (see also
Table 3) but not all those classifications are
easy to use. Van Mil et al. published an
overview of such classifications in 2004.7
A practical classification should at least
have the following characteristics:
• Focus on the problem itself not on its
cause or consequence;
• Problems should be clearly and uniquely
defined;
• The classification should be valid and the
coding reproducible
Some additional properties would make a
classification extra attractive:
• Preferably enable coding for both practice
and research;
• Suitable for the documentation needed
for the remuneration of  cognitive
services;
• Open structure, enabling introduction of
additional coding levels without the need
to change the basic structure;
• Offer an option to classify the
intervention.
Selection and validity issues†
The issue of definitions becomes once
again important when choosing a valid
classification for documenting DRPs. What
does one consider a DRP to be? In a
publication by Paulino et al, the uncertainty
or lack of knowledge about the aim or
function of the drug was considered to be a
drug related problem.8 For others it could be
the cause (potential cause) of a problem,
but not a problem in itself.
Not many DRP-classifications have been
tested for validity and reproducibility. For
both the PCNE Classification and Westerlund
system testing is almost continuous. Some
usability data are also available for the
Revised Granada Consensus, in comparison
with the PCNE classification.9 But for other
classifications such data cannot be
retrieved.
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Like for other classification or
instruments, for DRP classifications it is also
important that users can consider different
aspects of the instruments. There are eight
criteria that should be considered in the
selection of drug related problem
classification and those criteria in the mean
time also constitute criteria for validation.
Appropriateness: is the classification
content appropriate to the questions which
the application seeks to address?
Acceptability: is the classification
acceptable to pharmacists and researchers?
Feasibility: is the classification easy to
use and process?
Interpretability: how interpretable are
the codes of the classification?
Precision: how precise are the codes of
the classification?
Reliability: does the classification
produce results that are reproducible and
internally consistent?
Validity: does the classification
document what it claims to measure?
Responsiveness: does the classification
offer options to follow interventions and
outcomes of interventions?
These criteria are not uniformly
described in the literature; nor can they be
prioritised in terms of importance, rather
they should be considered in relation to the
proposed application of a DRP classification.
Conclusion
The concept of drug related problems is
essential for pharmaceutical care, and the
pharmaceutical care process. Nevertheless,
documenting DRPs systematically in practice
or for research is difficult. There are a
number of instruments available. But the
available validation data for some
Figure 2: DRP-Registration Form V5.01 (PCNE Classification)
Patient number _______________
Age of patient _______________ Male Female
Name of medication _______________ Rx OTC
Main active substance _______________ New Refill
(ATC-Code(s))
No of drugs taken _______________ According to patient
According to
medication record
Problem discovered by patient
by pharmacy Date:___________
by physician
Description & comments:           Time spent on evaluation and intervention: min _________
TYPE OF PROBLEM (Code for max. 1 problem)
CAUSE OF DRP (Max. 3 codes)
TYPE OF INTERVENTION (Max. 3 codes)
OUTCOME OF INTERVENTION (Only one code)
ABC system
ASHP classification
Cipolle et al.
Granada consensus
Hanlon
Hepler/Strand
Krska et al.
Mackie
PAS
PCNE Classification
PI-doc
SHB-SEP
Westerlund classification
Table 3: List of DRP classifications7
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instruments show poor reproducibility.
There seems to be a difference in how
different professionals assess the drug
treatment process, and identify the
problems. This difference in skills is
enhanced by varying levels of actual
knowledge.
Documentation systems for other
professions also pose problems in practice.
The quality and correlates of medical records
in the ambulatory care setting are debatable
too.10
It is certain that actual and potential
drug related problems occur, and can be
corrected in order to improve the outcome
of pharmacotherapy. But there seems to be
little agreement on how to name and
classify these problems between both
researchers and practitioners alike.
